Literature DB >> 12150478

Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa.

P M Jeena1, P Pillay, T Pillay, H M Coovadia.   

Abstract

BACKGROUND: Diagnosis of tuberculosis (TB) in childhood is difficult and is compounded by HIV-1, as both diseases often co-exist and have many similar features. Most studies from developing countries have included subjects in whom the diagnosis of TB is suspected but not proven. We therefore compare the findings in HIV-infected and non-HIV-infected children with culture-proven TB.
METHODS: Records were obtained from the laboratory at King Edward VIII Hospital, Durban, South Africa, between January 1998 and December 1999. Children aged 0-12 years with proven pulmonary tuberculosis (sputum, gastric washing or endotracheal aspirate culture for Mycobacterium tuberculosis) from the paediatric medical wards and intensive care unit were included in the study. A retrospective chart review of demographic data, clinical presentation, diagnostic modalities for TB, HIV-1 result, management and outcome were evaluated.
RESULTS: Of 138 culture-proven cases of TB identified during the study period, the medical records of 118 (86%) could be traced. Of these, 57 (48%) were HIV-1 infected, 44 (37%) non-HIV-1-infected, and in 17 (14%) HIV-1 status was not determined. In contrast to previous studies, this study has shown that TB-HIV co-infection in children is common (48% of all culture-proven cases), the presentation of tuberculosis may be acute (43%), and supportive tests are individually only reliable in confirming a diagnosis in a third of cases. All culture evaluations for M. tuberculosis were positive by 8 weeks. Where other diseases often co-exist with TB and HIV infection and the pressure for hospital in-patient admissions are excessive, the diagnosis of tuberculosis could easily be missed (21.2%). Clubbing and age over 2 years were the most reliable indicators of underlying HIV-1 disease in a child with tuberculosis, while clinical features, radiology and supportive tests were found to be similar between HIV-infected and non-HIV-infected TB cases. Hospital-related mortality, all causes, was higher (17.5%) in the HIV-1-infected than the non-infected group (11.4%).
CONCLUSION: The changing pattern of presentation of childhood tuberculosis and the high prevalence of TB in HIV endemic areas has made it imperative to maintain a high index of suspicion, with culture evaluation being an important part of clinical practice.

Entities:  

Mesh:

Year:  2002        PMID: 12150478

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  44 in total

1.  Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.

Authors:  Tiyani E Mabunda; Nalezani J Ramalivhana; Yoswa M Dambisya
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection.

Authors:  S M Graham; D J Bell; S Nyirongo; R Hartkoorn; S A Ward; E M Molyneux
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Prevalence, characteristics, management, and outcome of pulmonary tuberculosis in HIV-infected children in the TREAT Asia pediatric HIV Observational Database (TApHOD).

Authors:  Tavitiya Sudjaritruk; Alan Maleesatharn; Wasana Prasitsuebsai; Siew Moy Fong; Ngoc Oanh Le; Thanh Thuy Thi Le; Pagakrong Lumbiganon; Nagalingeswaran Kumarasamy; Nia Kurniati; Rawiwan Hansudewechakul; Nik Khairulddin Nik Yusoff; Kamarul Azahar Mohd Razali; Azar Kariminia; Annette H Sohn; Virat Sirisanthana
Journal:  AIDS Patient Care STDS       Date:  2013-11-09       Impact factor: 5.078

4.  Risk factors for in-hospital mortality among children with tuberculosis: the 25-year experience in Peru.

Authors:  Peter C Drobac; Sonya S Shin; Pedro Huamani; Sidney Atwood; Jennifer Furin; Molly F Franke; Charmaine Lastimoso; Hernan del Castillo
Journal:  Pediatrics       Date:  2012-07-23       Impact factor: 7.124

5.  HIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria.

Authors:  O J Daniel; O A Adejumo; M Gidado; H A Abdur-Razzaq; E O Jaiyesimi
Journal:  Public Health Action       Date:  2015-09-21

6.  Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection.

Authors:  Sampson Antwi; Hongmei Yang; Anthony Enimil; Anima M Sarfo; Fizza S Gillani; Daniel Ansong; Albert Dompreh; Antoinette Orstin; Theresa Opoku; Dennis Bosomtwe; Lubbe Wiesner; Jennifer Norman; Charles A Peloquin; Awewura Kwara
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

7.  23-valent pneumococcal polysaccharide vaccine elicits hierarchical antibody and cellular responses in healthy and tuberculosis-cured elderly, and HIV-1-infected subjects.

Authors:  Huichang Huang; Xiaohua Qian; Rong Pan; Ling Shen; Shanshan Liang; Feifei Wang; Peng Zhang; Hongbo Shen; Zheng W Chen
Journal:  Clin Immunol       Date:  2018-05-09       Impact factor: 3.969

8.  Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.

Authors:  Geetha Ramachandran; A K Hemanth Kumar; P K Bhavani; T Kannan; S Ramesh Kumar; N Poorana Gangadevi; V V Banurekha; L Sekar; N Ravichandran; G Mathevan; G N Sanjeeva; Rajeshwar Dayal; Soumya Swaminathan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

9.  Challenges of Childhood TB/HIV Management in Malawi.

Authors:  G Poerksen; Pn Kazembe; Sm Graham
Journal:  Malawi Med J       Date:  2007-12       Impact factor: 0.875

10.  Pharmacokinetics of First-Line Antituberculosis Drugs Using WHO Revised Dosage in Children With Tuberculosis With and Without HIV Coinfection.

Authors:  Awewura Kwara; Anthony Enimil; Fizza S Gillani; Hongmei Yang; Anima M Sarfo; Albert Dompreh; Antoinette Ortsin; Lawrence Osei-Tutu; Sandra Kwarteng Owusu; Lubbe Wiesner; Jennifer Norman; Jaclynn Kurpewski; Charles A Peloquin; Daniel Ansong; Sampson Antwi
Journal:  J Pediatric Infect Dis Soc       Date:  2015-05-26       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.